Literature DB >> 12041954

Infectious diseases in systemic lupus erythematosus: risk factors, management and prophylaxis.

Barri J Fessler1.   

Abstract

Infections are one of the leading causes of morbidity and mortality in patients with systemic lupus erythematosus (SLE). Therapeutic, disease-related and genetic factors all contribute to a lupus patient's increased susceptibility to infections. Although bacterial pathogens are the most common cause of infections, a wide variety of pathogens have been reported. In high-risk populations, identification and treatment of chronic infections such as tuberculosis, hepatitis B or human immunodeficiency virus, are important prior to the institution of immunosuppression to prevent reactivation or exacerbation of the infection. Judicious use of corticosteroids and cytotoxic drugs is critical in limiting infectious complications. Vaccines against influenza and pneumococcus appear to be safe and immunogenic in SLE patients and their routine administration should be encouraged. Copyright 2002 Elsevier Science Ltd.

Entities:  

Mesh:

Year:  2002        PMID: 12041954     DOI: 10.1053/berh.2001.0226

Source DB:  PubMed          Journal:  Best Pract Res Clin Rheumatol        ISSN: 1521-6942            Impact factor:   4.098


  32 in total

1.  Fatal sepsis by Klebsiella pneumoniae in a patient with systemic lupus erythematosus: the importance of postmortem microbiological examination for the ex post diagnosis of infection.

Authors:  Cristian D'Ovidio; Arianna Pompilio; Valentina Crocetta; Giovanni Gherardi; Aldo Carnevale; Giovanni Di Bonaventura
Journal:  Int J Legal Med       Date:  2015-02-13       Impact factor: 2.686

2.  Serious infections in patients with rheumatoid arthritis and other immune-mediated connective tissue diseases exposed to anti-TNF or rituximab: data from the Spanish registry BIOBADASER 2.0.

Authors:  Tatiana Cobo-Ibáñez; Miguel Ángel Descalzo; Estibaliz Loza-Santamaría; Loreto Carmona; Santiago Muñoz-Fernández
Journal:  Rheumatol Int       Date:  2014-01-11       Impact factor: 2.631

3.  The risk of tuberculosis in SLE patients from an Asian tertiary hospital.

Authors:  Yong Yang; Julian Thumboo; Ban Hock Tan; Thuan Tong Tan; Chern Hui Jeffrey Fong; Han Seong Ng; Kok Yong Fong
Journal:  Rheumatol Int       Date:  2017-03-12       Impact factor: 2.631

4.  Influenza vaccination responses in human systemic lupus erythematosus: impact of clinical and demographic features.

Authors:  Sherry R Crowe; Joan T Merrill; Evan S Vista; Amy B Dedeke; David M Thompson; Scott Stewart; Joel M Guthridge; Timothy B Niewold; Beverly S Franek; Gillian M Air; Linda F Thompson; Judith A James
Journal:  Arthritis Rheum       Date:  2011-08

Review 5.  Comparison of national clinical practice guidelines and recommendations on vaccination of adult patients with autoimmune rheumatic diseases.

Authors:  Despoina Papadopoulou; Nikolaos V Sipsas
Journal:  Rheumatol Int       Date:  2013-12-10       Impact factor: 2.631

6.  Rituximab-treated patients have a poor response to influenza vaccination.

Authors:  Robert A Eisenberg; Abbas F Jawad; Jean Boyer; Kelly Maurer; Kenyetta McDonald; Eline T Luning Prak; Kathleen E Sullivan
Journal:  J Clin Immunol       Date:  2012-10-14       Impact factor: 8.317

Review 7.  Immunization in Patients with Rheumatic Diseases: A Practical Guide for General Practitioners.

Authors:  Piyush Ranjan; Avinash Chakrawarty; Archana Kumari; Jitendra Kumar
Journal:  J Clin Diagn Res       Date:  2015-05-01

8.  Effect of lower dose intravenous cyclophosphamide on remission induction in Korean patients with lupus nephritis.

Authors:  Sang-Seokg Seong; Chan-Bum Choi; Hye-Ryeon Yun; Yoon-Jeong Kim; Yoon-Kyoung Sung; Sang-Cheol Bae
Journal:  Rheumatol Int       Date:  2007-10-09       Impact factor: 2.631

9.  Death-related factors of systemic lupus erythematosus patients associated with the course of disease in Chinese populations: multicenter and retrospective study of 1,958 inpatients.

Authors:  Jiang Zhen; Sun Ling-Yun; Zou Yao-Hong; Wang Xiang-Dang; Pan Jie-Ping; Zhang Miao-Jia; Tao Juan; Zhang Yu; Tan Kui-Lin; Li Jing; Chen Zhi-Wei; Ding Xiang; Qian Xian; Da Zhan-Yun; Wang Mei-Mei; Pan Wen-You
Journal:  Rheumatol Int       Date:  2012-12-21       Impact factor: 2.631

10.  Mice chronically fed high-fat diet have increased mortality and disturbed immune response in sepsis.

Authors:  Louise Strandberg; Margareta Verdrengh; Maria Enge; Niklas Andersson; Sylvie Amu; Karin Onnheim; Anna Benrick; Mikael Brisslert; Johan Bylund; Maria Bokarewa; Staffan Nilsson; John-Olov Jansson
Journal:  PLoS One       Date:  2009-10-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.